UK markets closed

Immunovia AB (publ) (0G8X.L)

LSE - LSE Delayed price. Currency in SEK
Add to watchlist
119.81-9.19 (-7.13%)
At close: 5:19PM BST
Full screen
Previous close129.00
Open119.81
Bid0.00 x 0
Ask0.00 x 0
Day's range119.81 - 119.81
52-week range119.81 - 119.81
Volume1
Avg. volumeN/A
Market cap2.314B
Beta (5Y monthly)1.25
PE ratio (TTM)N/A
EPS (TTM)-6.93
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Immunovia, Inc. Receives Final Approval to Begin Patient Testing with the IMMray® PanCan-d Test

    MARLBOROUGH, Mass., August 04, 2021--Today, Immunovia, Inc., the American subsidiary of Immunovia AB (Nasdaq Stockholm: IMMNOV), announced that it has received final approval to begin patient testing for the IMMray® PanCan-d test – the first blood test on the market dedicated to the early detection of pancreatic cancer. This approval was received from the Massachusetts Department of Public Health on August 3, 2021. Immunovia, Inc. received its CLIA Certificate of Registration on June 21, 2021 (C